# Profiling Spike Protein Antibody Response Post COVID-19 Booster

> **NCT05476822** · — · WITHDRAWN · sponsor: **David Grant U.S. Air Force Medical Center**

## Conditions studied

- COVID-19 Booster
- Spike Protein IgG Antibody

## Interventions

- **DIAGNOSTIC_TEST:** Obtain antibody titers

## Key facts

- **NCT ID:** NCT05476822
- **Lead sponsor:** David Grant U.S. Air Force Medical Center
- **Sponsor class:** FED
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-08
- **Primary completion:** 2023-06
- **Final completion:** 2023-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Not submitted for IRB approval. No participants were enrolled
- **Last updated:** 2023-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05476822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05476822, "Profiling Spike Protein Antibody Response Post COVID-19 Booster". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05476822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*